Skip to search formSkip to main contentSkip to account menu

Aplastic Anemia

Known as: Aplastic anemia NOS, ANEMIA, APLASTIC, Anemia, Aplastic [Disease/Finding] 
Anemia resulting from bone marrow failure (aplastic or hypoplastic bone marrow). The production of erythroblasts and red cells is markedly decreased… 
National Institutes of Health

Related topics

Related topics

41 relations

Broader (5)

AnemiaAplastic bone marrowMYELODYSPLASTIC SYNDROMEMyeloproliferative disease
Aplasia, NOSAregenerative anemiaBone Marrow DiseasesBone Marrow Transplantation

Narrower (6)

Aplastic anemia, idiopathicBone Marrow failure syndromesFanconi AnemiaPure Red-Cell Aplasia

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Current concepts in the pathophysiology and treatment of aplastic anemia.
  • N. Young
  • Hematology. American Society of Hematology…
  • 2013
  • Corpus ID: 9759071
Historically viewed in isolation as an odd, rare, and invariably fatal blood disease, aplastic anemia is now of substantial… 
Highly Cited
2011
Highly Cited
2011
Horse versus rabbit antithymocyte globulin in acquired aplastic anemia.
BACKGROUND In severe acquired aplastic anemia, hematopoietic failure is the result of immune-mediated destruction of bone marrow… 
Review
2010
Review
2010
Beta-thalassemia
Beta-thalassemia is caused by the reduced (beta+) or absent (beta0) synthesis of the beta globin chains of the hemoglobin… 
Review
2006
Review
2006
Current concepts in the pathophysiology and treatment of aplastic anemia.
Aplastic anemia, an unusual hematologic disease, is the paradigm of the human bone marrow failure syndromes. Almost universally… 
Highly Cited
2005
Highly Cited
2005
Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.
BACKGROUND Mutations in TERC, the gene for the RNA component of telomerase, cause short telomeres in congenital aplastic anemia… 
Highly Cited
2003
Highly Cited
2003
Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome.
CONTEXT In most patients, aplastic anemia results from T-cell-mediated immune destruction of bone marrow. Aplastic anemia can be… 
Review
2000
Review
2000
Progress with Light‐Emitting Polymers
Light-emitting polymers have been studied intensively as materials for light-emitting diodes (LEDs). Here research efforts toward… 
Review
1997
Review
1997
The pathophysiology of acquired aplastic anemia.
Plastic anemia, which is pancytopenia with a fatty or “empty” bone marrow, is remarkable for the simplicity of its pathologic… 
Highly Cited
1996
Highly Cited
1996
Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients.
Risk factors for the development of a new (secondary) malignancy after marrow transplantation are still incompletely defined. In… 
Highly Cited
1974
Highly Cited
1974
CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S
Sixty-one evaluable patients, 19 with advanced aplastic anemia and 42 with end stage hematological malignancies, were conditioned… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)